Genekor Medical S.A is a multinational molecular diagnostics company primarily focused in Oncology, Cardiology and Neurology. It was founded in 2007 and operates molecular biology laboratories with state of the art equipment. Our passionate team, is composed of board-certified internationally recognized and published scientists and doctors, sharing the same vision on quality healthcare and working together in order to provide patients and physicians with accurate, actionable information and continuous support towards successful precision medicine application. Our mission is to revolutionize the personalized treatment of patients by developing and offering highly sensitive and specific molecular assays that are applicable in everyday clinical practice, incorporating state-of-the-art technology and assisting physicians in applying cutting edge tools for individualized medicine worldwide The clinical expertise of Genekor Medical S.A. focuses on: • Response to Targeted Therapies • Detection of Hereditary Cancer • Early Detection of pancreatic cancer • Detection Inherited Cardiovascular Diseases • Detection of Inherited Neurological Disorders • Pharmacogenomics • Genetic Counseling • Custom Genetic Testing • Innovative Technological Platforms (OncotypeDX Breast™, prime DX®, HerediGENE®, CordisDX®, Cerebrum®DX, Signatera®) The specialized laboratories of GeneKor Medical S.A. are accredited by the Hellenic Accreditation Systems S.A (ESYD) under the terms of the ELOT EN ISO 15189:2012 (Cert. No. 822). Certified with ELOT EN ISO 9001:2015 (Cert. No. 041150049) and ELOT ISO/IEC 27001:2013 (Cert.No 048190009) by TUV NORD HELLAS. At Genekor, we are devoted to offering services of the highest quality, by constantly monitoring the scientific developments in the health sector, updating our laboratory equipment and maximizing our levels of accuracy and reliability.